Head and Neck Cancer Trial, Recruiting (NCT06077643)

Head and Neck Cancer Trial, Recruiting NCT06077643 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06077643 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had your voice box (larynx) fully removed at Bichat Hospital or HEGP within the last four years
You have finished all treatments related to the condition that led to your voice box being removed
You are able to travel to Bichat Hospital to attend all four sessions
You are 18 years of age or older
You have been given full information about how the research works and what it involves

Who may not be able to join:

You have significant physical limitations that affect your daily activities and ability to care for yourself (confirm with trial site)
You do not speak or understand French
You are not enrolled in French social security or a similar basic health coverage scheme (CMU)
You are currently under a legal protection arrangement, such as guardianship or curatorship
You have indicated that you do not wish to take part after being informed about the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06077643

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

More information: https://clinicaltrials.gov/study/NCT06077643

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had your voice box (larynx) fully removed at Bichat Hospital or HEGP within the last four years
You have finished all treatments related to the condition that led to your voice box being removed
You are able to travel to Bichat Hospital to attend all four sessions
You are 18 years of age or older
You have been given full information about how the research works and what it involves

Who may not be able to join:

You have significant physical limitations that affect your daily activities and ability to care for yourself (confirm with trial site)
You do not speak or understand French
You are not enrolled in French social security or a similar basic health coverage scheme (CMU)
You are currently under a legal protection arrangement, such as guardianship or curatorship
You have indicated that you do not wish to take part after being informed about the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

10 October 2023

Est. completion

10 June 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Differences in quality of life scores before and after the program, between the program and non-program control groups.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov